Globally deimmunized lysostaphin evades human immune surveillance and enables highly efficacious repeat dosing

There is a critical need for novel therapies to treat methicillin-resistant Staphylococcus aureus (MRSA) and other drug-resistant pathogens, and lysins are among the vanguard of innovative antibiotics under development. Unfortunately, lysins’ own microbial origins can elicit detrimental antidrug ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hongliang, Brooks, Seth A., Eszterhas, Susan, Heim, Spencer, Li, Liang, Xiong, Yan Q., Fang, Yongliang, Kirsch, Jack R., Verma, Deeptak, Bailey-Kellogg, Chris, Griswold, Karl E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467700/
https://www.ncbi.nlm.nih.gov/pubmed/32917596
http://dx.doi.org/10.1126/sciadv.abb9011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467700/
https://www.ncbi.nlm.nih.gov/pubmed/32917596
http://dx.doi.org/10.1126/sciadv.abb9011

Ejemplares similares